Clinical Trial Update: Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV) [Phase 3]

View source ↗

Summary

This clinical trial update describes Surovatamig as consolidation therapy for chronic lymphocytic leukemia or small lymphocytic lymphoma with unmutated IGHV in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Surovatamig

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV | Phase 3 | Status: NOT_YET_RECRUITING